$POET If wafer and component availability are indeed so bottlenecked, Poet having ~750M in cash and having already secured wafer capacity isn’t a small thing.
A lot of photonic startups exist who will take a back seat due to input unavailability. Starting to think Lumilens needed Poet for more than just the tech. Poet has manufacturing facilities and supplies that Lumilens would be hard pressed to acquire otherwise.
1
1
68
A dedicated WhatsApp group for $POET holders is now online!
All investors holding $POET stock are welcome to join this exclusive group to discuss the stock and get the latest information.
Click the link to send“stock” join: stockswhatsapp.app/9UOw3k
Our assistant Jennifer is available to assist you anytime!
8
A dedicated WhatsApp group for $VKTX holders is now online!
All investors holding $VKTX stock are welcome to join this exclusive group to discuss the stock and get the latest information.
Click the link to send“stock” join: stockswhatsapp.app/9UOw3k
Our assistant Jennifer is available to assist you anytime!
$VKTX
KLRA has a very good drug but not a great one. What would you expect a CEO to say when his drug lacks the half life to support monthly dosing?
VK2735 appears to be a great drug with much more potential ways to generate revenue than Ribupatide.
A silver tongued CEO is a double edged sword.
VK2735 is BIC 👇👇👇👇
1
62
A dedicated WhatsApp group for $GRRR holders is now online!
All investors holding $GRRR stock are welcome to join this exclusive group to discuss the stock and get the latest information.
Click the link to send“stock” join: stockswhatsapp.app/9UOw3k
Our assistant Jennifer is available to assist you anytime!
$GRRR
What if the tighter US chip restrictions actually work in our favour?
Jay could be positioning GRRR as a trusted, US-aligned AI infrastructure partner across APAC.
GRRR already has deep ties with Taiwan's government and is an NVIDIA Solutions Partner. If NVIDIA and the US trust GRRR to deploy GPUs across Southeast Asia while keeping restricted Chinese access out, this could become a serious competitive advantage.
As regulations tighten, trusted operators become more valuable. Less competition, stronger moat, bigger opportunity.
Maybe Jay is building something much bigger than the market realises.🔥
1
195
A dedicated WhatsApp group for $IBRX holders is now online!
All investors holding $IBRX stock are welcome to join this exclusive group to discuss the stock and get the latest information.
Click the link to send“stock” join: stockswhatsapp.app/9UOw3k
Our assistant Jennifer is available to assist you anytime!
$IBRX IBRX chose to do BCG resistant nmibc first because that setting is faster and FDA was more lenient because of the unmet need. Approval in the Naive setting will likely crush any competitor who is not in that setting such as Inlexzo, crestimigene etc for a specific reason. People become BCG resistant largely because of immune collapse. Anktiva is able to restore the immune system and make the patient once again sensitive to BCG. In the Naive setting, many of those patient will not experience BCG resistance because Anktiva will maintain immune system. It's much harder to restore immunity and bcg sensitivity in the 2nd line after patient fail the current standard of BCG only. The Naive trial data suggests that Anktiva will stop MANY patients from going to second line treatment, which will mean far less need for Inlexzo, crestimogene and Anktiva in second line. Great efficacy in Naive first line will starve second line.
1
54
A dedicated WhatsApp group for $IREN holders is now online!
All investors holding $IREN stock are welcome to join this exclusive group to discuss the stock and get the latest information.
Click the link to send“stock” join: stockswhatsapp.app/9UOw3k
Our assistant Jennifer is available to assist you anytime!
$IREN After $NVDA earnings, I'm even more bullish on $IREN.
What really caught my attention was NVIDIA's discussion around agentic AI and just how massive this could become.
Now look at IREN's moves, especially Mirantis. To me, they're hinting at ambitions well beyond GPU rentals. Their own cloud platform, managed services, potentially a token factory, agentic AI infrastructure and multiple recurring revenue streams.
And let's not overlook the land and power IREN has already secured. NVIDIA made it clear how critical these are becoming as AI infrastructure expands.
Financing and execution remain the challenges, and some of this is my own speculation.
But connect the dots... land, power, GPUs, cloud, Mirantis and agentic AI. The pieces are coming together.
1
151
$VKTX
KLRA has a very good drug but not a great one. What would you expect a CEO to say when his drug lacks the half life to support monthly dosing?
VK2735 appears to be a great drug with much more potential ways to generate revenue than Ribupatide.
A silver tongued CEO is a double edged sword.
VK2735 is BIC 👇👇👇👇
A dedicated WhatsApp group for $VKTX holders is now online!
All investors holding $VKTX stock are welcome to join this exclusive group to discuss the stock and get the latest information.
Click the link to send“stock” join: stockswhatsapp.app/9UOw3k
Our assistant Jennifer is available to assist you anytime!
22
$CLOV linkedin confirmation of counterpart use in Mississippi
Largest health centre in the state by the way...
2
7
549
A dedicated WhatsApp group for $CLOV holders is now online!
All investors holding $CLOV stock are welcome to join this exclusive group to discuss the stock and get the latest information.
Click the link to send“stock” join: stockswhatsapp.app/9UOw3k
Our assistant Jennifer is available to assist you anytime!
26
$GRRR
What if the tighter US chip restrictions actually work in our favour?
Jay could be positioning GRRR as a trusted, US-aligned AI infrastructure partner across APAC.
GRRR already has deep ties with Taiwan's government and is an NVIDIA Solutions Partner. If NVIDIA and the US trust GRRR to deploy GPUs across Southeast Asia while keeping restricted Chinese access out, this could become a serious competitive advantage.
As regulations tighten, trusted operators become more valuable. Less competition, stronger moat, bigger opportunity.
Maybe Jay is building something much bigger than the market realises.🔥
A dedicated WhatsApp group for $GRRR holders is now online!
All investors holding $GRRR stock are welcome to join this exclusive group to discuss the stock and get the latest information.
Click the link to send“stock” join: stockswhatsapp.app/9UOw3k
Our assistant Jennifer is available to assist you anytime!
51
$HTZ by the Q4 earnings, I am looking for the following,
1) Reaffirm $500M~$850M EBITDA for 2027 with $650M as midpoint
2) 25% retirement of non-vehicle debt using the proceeds from the franchise conversion and other low-performing asset sales
3) 8% interest rate on the remaining of approx. $3.9B in non vehicle debt, extended to 2030 and beyond maturity
4) approx. 2M shares diluted from exchangeable notes (540M shares total outstanding
Assign 8x EBITDA for Hertz (from $650M midpoint, I believe Avis is at 10x ) puts Hertz at around $4.33 per share in my calculation. I think this is a good midpoint valuation with fairly decent probability of success.
Now, Gil West has 2.2M share units of restricted stocks tied to stock performance. $10 sustained for 90 days will get him 450k shares vested. only $4.5M. $1B EBITDA will get him there. Reaching all milestones to $20 stock price will put his equity package at $84M. He has until April 2029 to do it. Would you let this go to bankrupt? nah..
1
5
293
A dedicated WhatsApp group for $HTZ holders is now online!
All investors holding $HTZ stock are welcome to join this exclusive group to discuss the stock and get the latest information.
Click the link to send“stock” join: stockswhatsapp.app/9UOw3k
Our assistant Jennifer is available to assist you anytime!
28
$IBRX IBRX chose to do BCG resistant nmibc first because that setting is faster and FDA was more lenient because of the unmet need. Approval in the Naive setting will likely crush any competitor who is not in that setting such as Inlexzo, crestimigene etc for a specific reason. People become BCG resistant largely because of immune collapse. Anktiva is able to restore the immune system and make the patient once again sensitive to BCG. In the Naive setting, many of those patient will not experience BCG resistance because Anktiva will maintain immune system. It's much harder to restore immunity and bcg sensitivity in the 2nd line after patient fail the current standard of BCG only. The Naive trial data suggests that Anktiva will stop MANY patients from going to second line treatment, which will mean far less need for Inlexzo, crestimogene and Anktiva in second line. Great efficacy in Naive first line will starve second line.
A dedicated WhatsApp group for $IBRX holders is now online!
All investors holding $IBRX stock are welcome to join this exclusive group to discuss the stock and get the latest information.
Click the link to send“stock” join: stockswhatsapp.app/9UOw3k
Our assistant Jennifer is available to assist you anytime!
29
$IREN After $NVDA earnings, I'm even more bullish on $IREN.
What really caught my attention was NVIDIA's discussion around agentic AI and just how massive this could become.
Now look at IREN's moves, especially Mirantis. To me, they're hinting at ambitions well beyond GPU rentals. Their own cloud platform, managed services, potentially a token factory, agentic AI infrastructure and multiple recurring revenue streams.
And let's not overlook the land and power IREN has already secured. NVIDIA made it clear how critical these are becoming as AI infrastructure expands.
Financing and execution remain the challenges, and some of this is my own speculation.
But connect the dots... land, power, GPUs, cloud, Mirantis and agentic AI. The pieces are coming together.
A dedicated WhatsApp group for $IREN holders is now online!
All investors holding $IREN stock are welcome to join this exclusive group to discuss the stock and get the latest information.
Click the link to send“stock” join: stockswhatsapp.app/9UOw3k
Our assistant Jennifer is available to assist you anytime!
60
$KEEL Encouraging to see some positive headlines sprouting up from the rubble left behind by the negative news cycle that swept through the AI trade. There's no doubt in my mind that it weighed heavily on investor sentiment and prompted an exodus. Now I'm starting to see stories about communities that have benefitted from hosting datacenters. Ben got it right at Cantor. Public perception will shift when misinformation is dispelled. I'm seeing more mention of the revenue stream that AI tools are beginning to generate, along with news about companies adopting flexible financing options to alleviate capex costs. The revolution is still cutting its teeth. Hopefully a more balanced view of things is beginning to assert itself and we can get this ship turned around.
3
8
645
A dedicated WhatsApp group for $KEEL holders is now online!
All investors holding $KEEL stock are welcome to join this exclusive group to discuss the stock and get the latest information.
Click the link to send“stock” join: stockswhatsapp.app/9UOw3k
Our assistant Jennifer is available to assist you anytime!
27
$GTBIF 5 investment reasons featured:
1. Revenue growth — $324.4M, up 11.3%.
2. Strong underlying earnings — $89.4M normalized EBITDA.
3. Cash position — $316M cash.
4. Retail expansion — 27 Florida RISE locations.
5. Potential catalysts — $50M share repurchase authorization, Schedule III developments and Virginia adult-use market opportunity in July 2027.
1
1
133
A dedicated WhatsApp group for $GTBIF holders is now online!
All investors holding $GTBIF stock are welcome to join this exclusive group to discuss the stock and get the latest information.
Click the link to send“stock” join: stockswhatsapp.app/9UOw3k
Our assistant Jennifer is available to assist you anytime!
13
$NWBO It was a battle yesterdsy. Above average volume of 6.3 million. Nice close above 0.15. It is absolutely obvious, the desperation to keep the price from rising. The shorts must have a very high count of FTDs , behaving this way. Who in the world would still try to short a 15 cents stock for a financial gain? They need hiiiiiigh volume days, 100 million days on to cover. That’s why they keep it low. The amount of shares shorted must be gigantic. Why else this strategy and struggle at 15 cents. This will have huge moves. Big Pharma had paid tens of billions for a chance in proof of concept. DCVAX is effective, safe and now scalable, applicable to potentially all cancers, trials speak the results, combos speak the results, brain power talent is joining the team, manufacturing cooperation with government run organizations, and this trades below 300 million market cap. Just keep buying with your lunch money. If you don’t see it, stop investing anywhere . This is beyond obvious
1
7
524
A dedicated WhatsApp group for $NWBO holders is now online!
All investors holding $NWBO stock are welcome to join this exclusive group to discuss the stock and get the latest information.
Click the link to send“stock” join: stockswhatsapp.app/9UOw3k
Our assistant Jennifer is available to assist you anytime!
80
$PLUG Plenty of upside potential with little downside risk as we move into this quarter’s positive EBITDA and 2027’s positive operating income.
1
4
377
A dedicated WhatsApp group for $PLUG holders is now online!
All investors holding $PLUG stock are welcome to join this exclusive group to discuss the stock and get the latest information.
Click the link to send“stock” join: stockswhatsapp.app/9UOw3k
Our assistant Jennifer is available to assist you anytime!
13
$INO Excellent Presentation: Delivering on the Promise of DNA Medicine.
1
1
140
A dedicated WhatsApp group for $INO holders is now online!
All investors holding $INO stock are welcome to join this exclusive group to discuss the stock and get the latest information.
Click the link to send“stock” join: stockswhatsapp.app/9UOw3k
Our assistant Jennifer is available to assist you anytime!
35













